Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 821569, 12 pages
http://dx.doi.org/10.1155/2014/821569
Research Article

Caffeamide 36-13 Regulates the Antidiabetic and Hypolipidemic Signs of High-Fat-Fed Mice on Glucose Transporter 4, AMPK Phosphorylation, and Regulated Hepatic Glucose Production

1Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, China Medical University, Taichung City 40402, Taiwan
2Department of Biotechnology, Asia University, Taichung City 41354, Taiwan
3Department of Internal Medicine, Fengyuan Hospital, Ministry of Health and Welfare, Fengyuan District, Taichung City 42055, Taiwan
4Graduate Institute of Pharmaceutical Science and Technology, College of Health Science, Central Taiwan University of Science and Technology, No. 666 Buzih Road, Beitun District, Taichung City 40601, Taiwan

Received 19 May 2014; Accepted 3 July 2014; Published 20 July 2014

Academic Editor: Cicero L. T. Chang

Copyright © 2014 Yueh-Hsiung Kuo et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Yueh-Hsiung Kuo, Cheng-Hsiu Lin, and Chun-Ching Shih, “Caffeamide 36-13 Regulates the Antidiabetic and Hypolipidemic Signs of High-Fat-Fed Mice on Glucose Transporter 4, AMPK Phosphorylation, and Regulated Hepatic Glucose Production,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 821569, 12 pages, 2014. https://doi.org/10.1155/2014/821569.